Primary and secondary carnitine deficiency Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: L-carnitine, 2-3 grams per day, divided into 2-3 divided doses, intramuscularly or intravenously
Retatrutide Phase 2 NEJM Trial: 48-Week Weight Loss Results Explained Retatrutide phase 2 NEJM data has positioned this investigational triple agonist as one of the most closely watched developments in obesity pharmacotherapy
Download our eBook to learn about the generation and function of active GLP-1 and why both are important aspects of type 2 diabetes research
If you find the dosing requirements difficult to manage, or if you miss doses frequently, speak to your diabetes care teamthey can explore whether Rybelsus remains the most suitable option for you or whether an alternative GLP-1 receptor agonist (such as a once-weekly injection) might be more practical for your lifestyle and circumstances
In the context of metabolic health, three mechanisms stand out
We combine advanced medical weight loss solutions with compassionate support to help you feel healthier, more confident, and in control of your wellness journey